Together, we are stronger.
Consolidation therapy for multiple myeloma
Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.
Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).
Brock has been cancer free for over a decade, thanks to the support we received from the Canadian Cancer Society.
How can you stop cancer before it starts?
Discover how your lifestyle choices can affect cancer risk and how you can take action with our interactive tool – It’s My Life!